• 2000 March 28

Company Description

Epirus Biopharmaceuticals develops biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.

EPIRUS is focusing on the central development of a broad pipeline of biosimilar monoclonal antibodies and therapeutic proteins, optimized for use within the SCALE disposable manufacturing system, and designed to be deployed in an 'In Market, For Market' manufacturing configuration.